Objective: To explore the role of clinical pharmacists in nutritional support therapy through the clinical practice of a child with intestinal failure-associated liver disease. Methods: According to the individual conditions of the child

clinical pharmacists participated into formulating the individualized nutritional support and pharmaceutical care regimen. Results: Under the nutritional support regimen formulated by clinical pharmacists and clinicians

the child grew well and the cholestasis was reduced

with total bilirubin decreased from 376.8 μmol/L to 121.6 μmol/L and direct bilirubin decreased from 274.7 μmol/L to 87.4 μmol/L. Conclusion: Parenteral nutrition and enteral nutrition are beneficial to sustain life for children with intestinal failure-associated liver disease

improve intestinal tolerance

reduce the incidence of complications

and improve outcomes.